Moreover, PDGFRA gene editing reduced spontaneous metastasis to the lung when injected in immunocompromised mice, indicating a beneficial role for PDGFRA inhibitors, such as imatinib to treat aggressive thyroid cancer [51]. The gene discussed is PDGFRA; the disease is thyroid cancer.